[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-445559-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-445559-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","op38-policy-perspective-on-next-generation-precision-health-in-the-new-zealand-health-system","OP38 Policy Perspective On Next-Generation Precision Health In The New Zealand Health System","","Policy Perspective outlines how New Zealand’s health system—covering 5.2 million people through public, private, and voluntary providers—can adapt health technology assessment approaches to next-generation precision health. Using a Long-Term Insights Briefing led by policymakers and developed with public and Māori/Pacific consultation, it synthesizes themes from stakeholders on evidence, investment pathways, equity dimensions, data sovereignty, and system efficiency. It concludes that HTA methods can guide trade-offs and support sustainable expansion of genomics and AI-enabled technologies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/op38-policy-perspective-on-next-generation-precision-health-in-the-new-zealand-health-system/445559/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/op38-policy-perspective-on-next-generation-precision-health-in-the-new-zealand-health-system/445559.png","ImageObject",300,407,{"name":42,"@type":43},"Eliana","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-29",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of the OP38 policy perspective session?","Question",{"text":63,"@type":64},"It describes New Zealand’s incremental progress in realizing and managing the opportunities and risks of precision health, and how HTA processes can support appropriate consideration of objectives and trade-offs.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the evidence and stakeholder input gathered?",{"text":68,"@type":64},"The New Zealand Ministry of Health produced a Long-Term Insights Briefing on precision health with consultation involving patients and the public, including deliberative consultation with Māori and Pacific peoples, plus input from government agencies, clinicians, researchers, industry, and patient organizations.",{"name":70,"@type":61,"acceptedAnswer":71},"What key themes emerged for future HTA in New Zealand?",{"text":72,"@type":64},"Themes include sustained and coordinated investment pathways, broader societal consideration of adoption impacts, explicit incorporation of multiple equity dimensions, attention to efficiency and financial sustainability, and maintaining data sovereignty.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},445559,1791007551,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":108,"slug":109},7,40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},"Research & Report",30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":107,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":22,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":30,"preview_page_count":4},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","OP37 How Can We Make Innovative Payment Schemes Work? Findings Of A European Union Horizon Europe Project  \nMichael Drummond ([mike.drummond@york.ac.uk](mike.drummond@york.ac.uk)), Vittoria Ardito, Ludovico Cavallaro and Oriana Ciani  \nIntroduction: Innovative payment schemes have been widely proposed as a solution for dealing with uncertainties in cost and outcomes associated with the introduction of new health technologies. These schemes incorporate risk sharing, either by changing the method of paying for the health technology or by requesting more long-term evidence on outcomes. However, payers’ experiences with these schemes are mixed.  \nMethods: A work package of the Health Innovation Next Generation Payment and Pricing Models (HI-PRIX) project is obtaining new evidence on the design and implementation of these schemes by:(i) undertaking a scoping review and classification of existing schemes, supplemented by interviews with national experts to identify schemes not in the published or gray literature; (ii) conducting a Delphi exercise with the key stakeholder groups involved in these schemes (payers, patient representatives, technology manufacturers, healthcare decision-makers), to identify the barriers and facilitatorsto developing schemes; and (iii) investigating several case studies to identify key learnings in the development of schemes.  \nResults: To date, more than 200 innovative pricing schemes have been identified across a broad range of technologies and applications. In addition, a novel classification has been developed to enable policymakers to search for schemes meeting specific objectives or having particular characteristics. Also, a preliminary search of the database of schemes, the Pay-for-Innovation Observatory ([hiprixhorizon.eu](hiprixhorizon.eu)), suggests that it will be possible to identify whether schemes with certain characteristics are more likely to be successful when applied to certain types of technologies (e.g., cell and gene therapies, rare disease treatments, medical devices), or designed to meet particular objectives, including equity enhancing purposes. Conclusions: Despite the challenges, innovative payment schemes still represent one of the best approaches for facilitating the costeffective introduction of new technologies under uncertainty. If policymakers can be assisted in selecting the best schemes to meet their particular objectives and are better informed of the main barriers and facilitators, then the success rate of these schemes will increase.  \nOP38 Policy Perspective On NextGeneration Precision Health In The New Zealand Health System  \nThomas Wilkinson ([tommy.wilkinson@health.govt. nz](tommy.wilkinson@health.govt. nz)), Alex Williams and James Oughton  \nIntroduction: The New Zealand health system provides universal health coverage to a population of 5.2 million, delivered through a range of public, private, and voluntary providers. New Zealand has extensive experience applying health technology assessment (HTA) to pharmaceuticals and vaccines. These models could potentially be adapted and applied to innovative precision health technologies that offer substantive potential health and equity benefits for patients and whānau (families), and health system financial sustainability. Methods: The New Zealand Ministry of Health developed a LongTerm Insights Briefing on Precision Health to highlight future trends, risks, and opportunities represented by genomics and artificial intelligence-enabled technologies. The briefing was developed collaboratively with consultation with patients and the public, including deliberative consultation with Māori and Pacific peoples. Organizational input was provided from across the sector including from government agencies, clinicians, researchers, industry, and patient organizations. The briefing was structured around key themes identified through engagement.  \nResults: The briefing identified multiple themes with important implications for any futu","cbCainmyOqMF3aMU","https://ap.wps.com/l/cbCainmyOqMF3aMU","pdf",33134,"English","# Introduction\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What is the purpose of the OP38 policy perspective session?\",\"answer\":\"It describes New Zealand’s incremental progress in realizing and managing the opportunities and risks of precision health, and how HTA processes can support appropriate consideration of objectives and trade-offs.\"},{\"question\":\"How was the evidence and stakeholder input gathered?\",\"answer\":\"The New Zealand Ministry of Health produced a Long-Term Insights Briefing on precision health with consultation involving patients and the public, including deliberative consultation with Māori and Pacific peoples, plus input from government agencies, clinicians, researchers, industry, and patient organizations.\"},{\"question\":\"What key themes emerged for future HTA in New Zealand?\",\"answer\":\"Themes include sustained and coordinated investment pathways, broader societal consideration of adoption impacts, explicit incorporation of multiple equity dimensions, attention to efficiency and financial sustainability, and maintaining data sovereignty.\"}]","OP38 Policy Perspective On Next-Generation Precision Health In The New Zealand Health System | PDF",1790712387]